Cite
APA Citation
Bartoletti, M., Pelizzari, G., Bortot, L., Giavarra, M., Vitale, M., Andreotti, V., Parnofiello, A., Scalone, S., Lombardi, D., Nicoloso, M., Bozza, C., Poletto, E., Sacco, C., Andreetta, C., Sorio, R., & Puglisi, F. (n.d.). eP795 Searching for the best maintenance therapy in platinum-sensitive recurrent ovarian cancer: bevacizumab or PARP-inhibitors? A network meta-analysis. International journal of gynecological cancer, 29, A437–A438. http://access.bl.uk/ark:/81055/vdc_100144714284.0x000019